Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits	Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, central nervous system disorder, epilepsy, nervous system disorder, visual epilepsy	Recruiting	Phase 4	2026-04-20		NCT04419272

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Miami VA Healthcare System	4
Portland VA Medical Center	13
VA Boston Healthcare System	17
VA New York Harbor Healthcare System	8
VA Office of Research and Development	472

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Miami VA Healthcare System, Miami, FL	Miami	United States	11
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA	Boston	United States	34
VA NY Harbor Healthcare System, New York, NY	New York	United States	14
VA Portland Health Care System, Portland, OR	Portland	United States	30